N.J.S.A 17:48E-35.5. Health service corporation, benefits for “off-label” drugs required

17:48E-35.5. Health service corporation, benefits for “off-label” drugs required

4. a. Except as otherwise provided in P.L.1992, C. 161 (C. 17B:27A-2 et al.) and P.L.1992, C. 162 (C. 17B:27A-17 et seq.), no group or individual health service corporation contract which provides benefits for expenses incurred in prescribing drugs approved by the federal Food and Drug Administration shall be delivered, issued, executed or renewed in this State, or approved for issuance or renewal in this State on or after the effective date of this act, unless the contract provides benefits to any subscriber or other person covered thereunder for expenses incurred in prescribing a drug for a treatment for which it has not been approved by the Food and Drug Administration if the drug is recognized as being medically appropriate for the specific treatment for which it has been prescribed in one of the following established reference compendia:

(1) the American Medical Association Drug Evaluations;

(2) the American Hospital Formulary Service Drug Information;

(3) the United States Pharmacopoeia Drug Information;

or, it is recommended by a clinical study or review article in a major-peer reviewed professional journal.

b. Notwithstanding the provisions of this section, coverage shall not be required for any experimental or investigational drug or any drug which the Food and Drug Administration has determined to be contraindicated for the specific treatment for which the drug has been prescribed. The benefits provided pursuant to this section shall be provided to the same extent as other benefits under the contract for drugs prescribed for a treatment approved by the Food and Drug Administration.

C. This section shall apply to all health service corporation contracts in which the health service corporation has reserved the right to change the premium.

d. Any coverage of a drug required by this section shall also include medically necessary services associated with the administration of the drug.

L.1993,C. 321,S.4.

Case(s):

Look up case for New Jersey Statute 17:48E-35.5. Health service corporation, benefits for “off-label” drugs required

Original Text maintained by the State of New Jersey:

NJ Maintained Unanotated Statutes References to 17:48E-35.5. Health service corporation, benefits for “off-label” drugs required

Previous: 17:48E-35.4 Health service corporation contract, mammogram examination benefits. Next: 17:48E-35.6. Health service corporation, benefits for health promotion

Disclaimer: Always check for the most up to date language of a statute. Every time a new law is enacted it has a possibility of changing the wording of a statute or override case law. These pages were created to assist in looking up and migrating between statutes easily. No accuracy is guaranteed. If you need help with researching law, contact an attorney.

Related Posts

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.